… to colistin in clinical isolates of A. … its combinations with imipenem, sulbactam, and colistin
in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. …

… minocycline dosed 200 mg IV q12 h against CRAB isolates … The impact of the colistin–carbapenem
combinations on the … conflicting reports of both clinical successes and failures [61, …

… A separate analysis of 3989 clinical isolates from the TEST … An in vitro study examined the
effect of colistin and minocycline when tested in combination against 13 imipenem-resistant A. …

… baumannii infections is particularly challenging. Methods: … the combination of vancomycin
and colistin combination in vitro … baumannii type strain and clinical isolates. In time-kill assays…

… activity against MDR Acinetobacter has been noted with minocycline in combination with
colistin or carbapenems [8, 9]. … on imipenem-resistant Acinetobacter baumannii clinical isolates …

… baumannii clinical isolates. With the exception of polymyxins … 9-t-butylglycylamido derivative
of minocycline) remain as the major … In vitro activity of tigecycline and colistin against clinical …

… assess the in vitro activity of different combinations of colistin, … has been found in clinical
isolates of Acinetobacter. It might … ) of imipenem-resistant and –susceptible isolates. Sulbactam …

… Two clinical isolates were used: one with an MIC to … for treatment of imipenem-resistant
Acinetobacter nosocomial … /sulbactam, colistin, and possibly doxycycline or minocycline may be …

… all 2006 isolates were susceptible to tigecycline and colistin, … these reports, all
imipenem-resistant MDR-AB isolates, in the … ciprofloxacin–levofloxacin or minocycline, which are …

… Data regarding use of minocycline combination are also sparse. A retrospective review …
vitro synergistic activity of antimicrobial agents in combination against clinical isolates of colistin…